Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

363

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

February 18, 2022

Study Completion Date

February 18, 2022

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Prospekta

Oral administration.

DRUG

Placebo

Oral administration.

Trial Locations (31)

117997

Russian National Research Medical University named after N.I. Pirogov/Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics, Moscow

119602

Research and Practical Center of Pediatric Psychoneurology of Moscow City Health Department/Consultative and polyclinic department, Moscow

129110

Moscow Regional Research Clinical Institute named after M.F. Vladimirsky/Neurology Department of Therapy Department, Moscow

150000

Yaroslavl State Medical University/Department of Polyclinic Pediatrics, Yaroslavl

170026

Regional Clinical Psychoneurological Dispensary/Outpatient clinic # 2, Tver'

192019

National Medical Research Center for Psychiatry and Neurology named after V.M. Bekhterev, Saint Petersburg

197341

"Llc Doctrina", Saint Petersburg

197376

Institute of the Human Brain named after N.P. Bekhtereva, Saint Petersburg

214018

Smolensk Regional Clinical Hospital/Children's neurological department, Smolensk

Smolensk Regional Clinical Hospital/Pediatric neurological department, Smolensk

241004

"Hospital Russian Railways - Medicine of the city of Bryansk", Bryansk

344000

"LLC Treatment and rehabilitation research center PHOENIX/Day hospital # 1", Rostov-on-Don

350007

Specialized Clinical Psychiatric Hospital # 1/Dispensary department, Krasnodar

355000

"LLC Sunterra", Stavropol

355038

Stavropol Regional Clinical Specialized Psychiatric Hospital # 1/Children's department # 17, Stavropol

390026

Ryazan State Medical University named after Acad. I.P. Pavlov/Department of Children's Diseases with a course of hospital pediatrics, Ryazan

410005

"LLC DNA Research Center", Saratov

410012

Saratov State Medical University named after V.I. Razumovsky/Department of Neurology. named after K.N. Tretyakov, Saratov

410028

City Clinical Hospital # 2 named after V.I. Razumovsky, Saratov

410038

Saratov City Psychoneurological Dispensary, Saratov

413124

Engels Psychiatric Hospital, Engel's

420012

Kazan State Medical University/Department of Neurology, Neurosurgery and Medical Genetics, Kazan'

420138

Children's Republican Clinical Hospital/Neurological department for the treatment of patients with CNS lesions with mental disorders, Kazan'

432017

Children's City Clinical Hospital of Ulyanovsk city, Ulyanovsk

454087

Regional Clinical Specialized Psychoneurological Hospital # 1/Children's dispensary department, Chelyabinsk

460006

Orenburg Regional Clinical Psychiatric Hospital # 1/Children's psychiatric department, Orenburg

603159

"Llc Nizhmedklinika", Nizhny Novgorod

603950

Privolzhsky Research Medical University/Department of Neurology, Psychiatry and Narcology FDPO, Nizhny Novgorod

614990

Perm State Medical University named after academician E.A. Wagner/Department of Neurology, Perm

620030

Sverdlovsk Regional Clinical Psychiatric Hospital/Pediatric and adolescent medical and diagnostic department, Yekaterinburg

620144

"LLC European Medical Center UMMC-Health/Children's polyclinic in the main branch", Yekaterinburg

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT04569357 - Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children | Biotech Hunter | Biotech Hunter